You are here

HPV

Roche Expands Global Access to Viral Assays to Aid Eradication Efforts

Roche Expands Global Access to Viral Assays to Aid Eradication Efforts

Medical Devices and Diagnostics Industry

Global Access Program

Flag link:

Merck's spending big to support Gardasil, and the HPV vaccine keeps pumping along

Merck's spending big to support Gardasil, and the HPV vaccine keeps pumping along

Fierce Pharma

Flag link:

Just One HPV Dose May Be Enough To Prevent Several Cancers

Just One HPV Dose May Be Enough To Prevent Several Cancers

Forbes

cervical cancer

Flag link:

Michael Becker, patient advocate and biotech exec, dies at 50

Michael Becker, patient advocate and biotech exec, dies at 50

BioCentury

Flag link:

Updated HPV Vaccine Recommendations Follow Big HPV Infection Drops Shown In New Study

Updated HPV Vaccine Recommendations Follow Big HPV Infection Drops Shown In New Study

Forbes

Flag link:

U.S. advisory panel stops short of broad recommendations for two common vaccines

U.S. advisory panel stops short of broad recommendations for two common vaccines

Stat

advisory panels

Flag link:

Merck's Gardasil blockbuster sales prompt $1B plant expansion

Merck's Gardasil blockbuster sales prompt $1B plant expansion

Fierce Pharma

drug manufacturing

Flag link:

Laser-activated eye cancer drug developer Aura Biosciences scores $40M in Medicxi-led round

Laser-activated eye cancer drug developer Aura Biosciences scores $40M in Medicxi-led round

Endpoints

Aura Biosciences

Flag link:

'Unprecedented' demand for Merck's Gardasil drives monster Q3

'Unprecedented' demand for Merck's Gardasil drives monster Q3

Fierce Pharma

Flag link:

Gardasil HPV Vaccine Approved for Use in Adults Up to Age 45, But Will This Age Group Get the Shot?

Gardasil HPV Vaccine Approved for Use in Adults Up to Age 45, But Will This Age Group Get the Shot?

Xtalks

Flag link:

FDA expands use of an HPV vaccine up to age 45

FDA expands use of an HPV vaccine up to age 45

Stat

Flag link:

HPV-related cancer rises, despite higher vaccination rates

HPV-related cancer rises, despite higher vaccination rates

Bizjournals.com

cervical cancer

Flag link:

No Ovarian Failure Risk After HPV Vaccine, Study Finds

No Ovarian Failure Risk After HPV Vaccine, Study Finds

Forbes

primary ovarian insufficiency

Flag link:

Roche is on the “SurePath” for Cervical Cancer Screening with Approval

Roche is on the “SurePath” for Cervical Cancer Screening with Approval

Medical Devices and Diagnostics Industry

Flag link:

Despite high-flying Gardasil sales, Merck executives see 'significant' opportunity ahead

Despite high-flying Gardasil sales, Merck executives see 'significant' opportunity ahead

Fierce Pharma

Flag link:

U.K. to offer Merck's Gardasil to boys after years of protests

U.K. to offer Merck's Gardasil to boys after years of protests

Fierce Pharma

Flag link:

HPV Vaccine Works to Reduce Abnormal Cells in Cohort of Women

HPV Vaccine Works to Reduce Abnormal Cells in Cohort of Women

Xtalks

cervical cancer

Flag link:

Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize DNA Immunotherapy product (VGX-3100) in Greater China

Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize DNA Immunotherapy product (VGX-3100) in Greater China

CP Wire

DNAi-based therapeutics

Flag link:

Inovio lands $23m in collab with ApolloBio for HPV immunotherapy

Inovio lands $23m in collab with ApolloBio for HPV immunotherapy

Drug Delivery Business News

Flag link:

HPV Vaccination Immunity Remains Strong 10 Years Later, Especially For Preteens

HPV Vaccination Immunity Remains Strong 10 Years Later, Especially For Preteens

Forbes

Flag link:

Pages